Cutera, Inc. (NASDAQ:CUTR) Short Interest Update

Cutera, Inc. (NASDAQ:CUTR) saw a significant increase in short interest in November. As of November 30th, there was short interest totalling 4,400,000 shares, an increase of 8.9% from the November 15th total of 4,040,000 shares. Based on an average daily volume of 290,700 shares, the days-to-cover ratio is currently 15.1 days.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Cutera in a report on Thursday, December 12th. They issued a “sell” rating for the company.

Cutera Stock Down 1.2 %

Shares of NASDAQ:CUTR traded down $0.00 during trading on Tuesday, hitting $0.35. 73,125 shares of the company traded hands, compared to its average volume of 854,234. The stock has a market capitalization of $7.06 million, a price-to-earnings ratio of -0.05 and a beta of 1.26. The business’s fifty day moving average is $0.50 and its 200-day moving average is $0.95. Cutera has a one year low of $0.28 and a one year high of $4.97.

Hedge Funds Weigh In On Cutera

Several institutional investors have recently made changes to their positions in CUTR. Squarepoint Ops LLC boosted its position in shares of Cutera by 164.5% during the second quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after buying an additional 70,870 shares during the period. Bank of Montreal Can lifted its position in Cutera by 14.2% in the second quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after purchasing an additional 35,248 shares during the period. Finally, Ground Swell Capital LLC acquired a new stake in Cutera in the second quarter worth approximately $37,000. 90.70% of the stock is owned by institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.